Search

Prednisolone and/or acyclovir for Bell’s palsy

Landmark Paper: Sullivan FM, Swan IRC, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell’s Palsy. N Engl J Med 2007;357(16):1598-607. Facial nerve paralysis as a consequence of Bell’s palsy can result in devastating long-term effects on...

Otology training in low- and middle-income countries: a view from within

It is recognised that hearing loss and ear disease are far more common in less affluent parts of the world, and that those countries are often least able to provide treatment; so how can we prioritise care for these patients?...

Managing sustainability

Planetary health needs to be addressed at a societal level for any meaningful impact to occur. As the global director of sustainability for a law firm, Marion Palmer provides an overview of the responsibilities of corporate organisations for both a...

Are we making progress on tinnitus?

One of the aspects of tinnitus that drew me into it becoming a major theme of my clinical and research work was how little work had been done when I began to see patients in the mid 1980s. This struck...

Benchmarking for innovation in healthcare ­– an approach from 
Down Under and a gap in the 
National Health Service?

Benchmarking is a process of comparison between the performance characteristics of separate, often competing, organisations intended to enable each participant to improve its own performance [1]. Often, in healthcare, benchmarking is carried out by central government departments or regional agencies...

The changing role of audiology

Audiology has changed dramatically in recent years. Cochlear implants and high power hearing aids have made hearing really available to children with essentially any degree of hearing loss. Those of us who have been in the field for a long...

Hearing loss and Alport syndrome

Alport syndrome (AS) includes a group of hereditary diseases caused by mutations in the COL4A3, COL4A4 or COL4A5 genes. These genes are responsible for the biosynthesis of α3, α4 and α5 collagen IV chains, which are located in the glomerular...

Rehabilitation of unilateral sensorineural hearing loss: bone vs air conduction

The re-routing of sound from the deafened ear to the hearing ear has been the mainstay of rehabilitation for SSD for many years. Both hearing aid and bone conduction technology have undergone significant advances over the past decade. This article...

Multidisciplinary approach to managing individuals with trisomy 21

Michelle Chung and Narad Mathura outline the Down syndrome one-stop clinic; a multidisciplinary clinic introduced at the Children & Young Persons Audiology Centre (CYPAC) at Guys and St Thomas’ NHS Foundation Trust for children and young people with Down syndrome....

Innovating around access to hearing services during the pandemic

COVID-19 has also presented its challenges to hearing healthcare providers and to the industry and, similarly, called for innovation and creativity. Dr Bromwich describes how these sectors are rising to the challenge. The reality of COVID-19 has been a challenging...

2020 Lancet Commission on dementia: a call to action for integrated hearing healthcare

Dr Georgiou’s summary of the 2020 update to the 2017 Lancet Commission underscores the importance of medical and hearing healthcare professionals working together to tackle the modifiable risk factors that affect individuals throughout their lives, to help delay or even...